Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine can reduce the risk of complications following ...

The Bill & Melinda Gates Foundation has teamed up with Intarcia Therapeutics to invest upwards of $140 million with the intent of developing the first once or twice-yearly anti-HIV prophylactic to ...

"The purpose of this study was to prospectively compare the use of the ActiveCare® [MCS Inc.; West Hills, California] mobile compression device with the use of warfarin therapy in regard to safety and ...

The FDA issued a Class I recall — the most serious recall classification — for some of Medtronic’s cardiac resynchronization therapy and implantable cardioverter defibrillators. Here are four things ...

Urokinase administration every 2 weeks significantly affects the rate of occlusive events in ports and tunneled catheters and of infectious events in external catheters compared with heparin ...

Of 500 physicians surveyed, 162 (32%) returned the survey. Characteristics of the respondents are displayed in Table I. The vast majority of physicians were male (87%) specializing in either ...

Feb. 27 (UPI) --Medtronic has recalled 48 implantable and cardiac resynchronization defibrillators that are failing to deliver the proper shock to pace a patient's heartbeat or revive a patient in ...

Show More From the Department of Surgery, Division of Pediatric Surgery, Penn State College of Medicine, Hershey; Department of Surgery, Children's Hospital of Pittsburgh, Pittsburgh, PA; Department ...